Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Anticancer Research|July 1, 1987
Mitoxantrone combined with vincristine, cyclophosphamide and fluorouracil for advanced breast cancer. A study of short-term response rateJ L Misset, R Metz, M Gil-Delgado, et al.Bulletin Du Cancer|January 1, 1989
[Response of bone metastases to medical treatment: definition of evaluation criteria and classification trials]D Belpomme, J P Droz, F N Marie, et al.European Journal of Cancer & Clinical Oncology|November 1, 1984
An EORTC phase II study of mitoxantrone in solid tumors and lymphomasR De Jager, P Cappelaere, J P Armand, et al.La Nouvelle Presse Medicale|March 31, 1979
[Cis-diammino-dichloro-platinum therapy of cancers; phase II therapeutic trial]M Hayat, M Bayssas, G Brulé, et al.European Journal of Cancer (Oxford, England : 1990)|May 1, 1996
A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapyB Audhuy, P Cappelaere, M Martin, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1992
A phase II trial of 10-ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck. The EORTC Head and Neck Cancer Cooperative GroupJ H Schornagel, J Verweij, P H de Mulder, et al.Bulletin Du Cancer|July 1, 1996
[Predictive value of the hemogram for myelotoxicity induced by the association of carboplatin-fluorouracil on the 4th day of the therapeutic regimen]P Cappelaere, C Fournier, F Rolland, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative GroupM Clavel, J B Vermorken, F Cognetti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group studyJ H Schornagel, J Verweij, P H de Mulder, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1982
Follow-up results from a randomized trial for T3 and T4 breast cancer patients: previous BCG immunotherapy improves response to chemotherapy in the relapse patientB Serrou, H Sancho-Garnier, P Cappelaere, et al.Pageof 7